Table 2 Comparison of parenclitic deviations (δ) between survivors and non-survivors in patients with ALF.

From: Application of physiological network mapping in the prediction of survival in critically ill patients with acute liver failure

Variables

Survivors

Non-survivors

p-value

δ-Chloride/bicarbonate

0.83 (0.44–1.24)

0.72 (0.39–1.23)

0.021

δ-pH/bicarbonate

0.04 (0.02–0.07)

0.05 (0.02–0.09)

0.001

δ-GCS/ALT

5.34 (2.92–5.94)

5.65 (3.35–6.25)

0.013

δ-Cr/ALP

1.20 (0.69–1.62)

0.93 (0.56–1.48)

0.043

δ-pH/Cr

0.04 (0.02–0.07)

0.06 (0.03–0.09)

< 0.001

δ-GCS/Na

2.18 (1.15–3.27)

2.42 (1.35–3.37)

0.043

δ-Lactate/Glu

1.60 (0.79–2.46)

2.00 (1.00–4.08)

0.001

δ-Urea/Bil

2.66 (1.55–4.69)

2.99 (1.69–6.09)

0.045

δ-Lactate/HR

1.53 (0.84–2.57)

1.82 (0.95–3.46)

0.015

δ-SpO2/RespR

0.97 (0.46–1.6)

1.03 (0.57–1.85)

0.043

  1. Cl chloride, AST aspartate transaminase, ALT alanine aminotransferase, GCS Glasgow Coma Score, Bil total bilirubin, ALP alkaline phosphatase, Cr serum creatinine, Na serum sodium, Glu blood glucose, HR heart rate, RespR respiratory rate, Temp temperature.
  2. The Mann‒Whitney U test or t-test was used for calculation of p-values (unadjusted) according to the distribution of the data (normal distribution test) and homogeneity of variances (Levene’s test).
Back to article page